Skip to main content

Table 1 Composition of the adjuvanted influenza vaccine formulations

From: Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial

Formulation

α -tocopherol (mg)

MPL (μg)

AS03C

2.97

0

AS03C-MPL25

2.97

25

AS03C-MPL50

2.97

50

AS03B

5.93

0

AS03B-MPL25

5.93

25

AS03B-MPL50

5.93

50

AS03A

11.86

0

AS03A-MPL25

11.86

25

  1. All formulations of the vaccine contained AS03, which is a squalene and α-tocopherol oil-in-water emulsion-based Adjuvant System. MPL is 3-O-desacyl-4’- monophosphoryl lipid A.